AN ACT TO PROHIBIT INDIVIDUALS, CORPORATIONS AND OTHER ENTITIES FROM ADVERTISING AND MARKETING MEDICAL CANNABIS IN ANY MEDIA WITHIN THE STATE OF MISSISSIPPI OR ADVERTISING MEDICAL CANNABIS IN ANY MANNER THAT CAN BE VIEWABLE OR OTHERWISE PERCEIVED AS A PUBLIC SPACE WITHIN THE STATE OF MISSISSIPPI; TO REQUIRE THE ATTORNEY GENERAL TO RECEIVE AND INVESTIGATE COMPLAINTS OF VIOLATIONS OF THIS PROVISION, AND TAKE SUCH LEGAL ACTIONS AS NECESSARY TO ENFORCE COMPLIANCE WITH THIS PROVISION; TO AMEND SECTION 41-137-39, MISSISSIPPI CODE OF 1972, TO PROHIBIT MEDICAL CANNABIS ESTABLISHMENTS AND PERSONS OR ENTITIES ACTING ON THEIR BEHALF FROM ADVERTISING AND MARKETING IN ANY MEDIA OR ADVERTISING IN ANY MANNER THAT CAN BE VIEWABLE OR OTHERWISE PERCEIVED AS A PUBLIC SPACE; TO AMEND SECTION 41-137-41, MISSISSIPPI CODE OF 1972, TO CONFORM TO THE PRECEDING PROVISION; AND FOR RELATED PURPOSES.
Impact
The enactment of HB1195 would directly influence existing state laws concerning the promotion and advertisement of medical cannabis. It aims to amend Sections 41-137-39 and 41-137-41 of the Mississippi Code to restrict medical cannabis establishments and affiliates from engaging in any advertisement that may be viewable in public spaces. This measure underscores Mississippi’s commitment to managing the distribution and public perception of medical cannabis amidst its legalization, ensuring that such establishments operate within tightly controlled marketing practices.
Summary
House Bill 1195 is an act aimed at prohibiting the advertising and marketing of medical cannabis within the state of Mississippi. This legislation specifically targets individuals, corporations, and other entities by restricting any form of cannabis promotion across various media outlets, including broadcast, electronic, and print. The underlying intention of the bill is to control how medical cannabis is presented to the public and to mitigate potential misuse or misrepresentation related to the product. Advertising limitations extend to scenarios where promotions could be visible or perceived in public places, thereby enforcing a strict regulatory framework around cannabis marketing.
Contention
Opposition towards HB1195 may arise from advocates arguing that such stringent advertising restrictions could limit access to vital information regarding medical cannabis. Proponents of the bill, however, argue that these regulations are necessary to maintain public health standards and to prevent the commercialization of medical cannabis, which could lead to misuse by the public, especially minors. The discussions around this bill underline a tension between promoting medical cannabis as a legitimate treatment option and ensuring it is not marketed in a manner that could be considered reckless or misleading.